scispace - formally typeset
R

Ralf Wiedemuth

Researcher at Dresden University of Technology

Publications -  12
Citations -  478

Ralf Wiedemuth is an academic researcher from Dresden University of Technology. The author has contributed to research in topics: Aurora B kinase & Survivin. The author has an hindex of 9, co-authored 11 publications receiving 367 citations.

Papers
More filters
Journal ArticleDOI

RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo

TL;DR: It is concluded that survivin is functionally relevant in gliomas and that PEI-mediated exogenous delivery of siRNA targeting Survivin is a promising strategy for glioblastoma therapy.
Journal ArticleDOI

Overcoming concealment effects of targeting moieties in the PEG corona: controlled permeable polymersomes decorated with folate-antennae for selective targeting of tumor cells.

TL;DR: The excellent biocompatibility, controlled permeability, targeted internalization, as well as selective cytotoxicity of such polymersomes set up the basis for properly smart carrier for targeted drug delivery.
Journal ArticleDOI

Chromosomal instability induced by increased BIRC5 /Survivin levels affects tumorigenicity of glioma cells

TL;DR: Overexpression of Survivin levels promote adaptive evolution of tumors through combining induction of genetic heterogeneity with inhibition of apoptosis and indicates a DNA-repair by non-homologous end joining recombination.
Journal ArticleDOI

Survivin safeguards chromosome numbers and protects from aneuploidy independently from p53

TL;DR: It is suggested that Survivin plays an essential role in proper amphitelic kinetochore-spindle assembly and that constraining Survivin’s mitotic function results in polyploidy and aneuploidsy which cannot be controlled by p53.